Seong A Kim

890 total citations
19 papers, 636 citations indexed

About

Seong A Kim is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Seong A Kim has authored 19 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Seong A Kim's work include Immunotherapy and Immune Responses (6 papers), Extracellular vesicles in disease (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Seong A Kim is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Extracellular vesicles in disease (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Seong A Kim collaborates with scholars based in South Korea, Japan and United States. Seong A Kim's co-authors include In‐San Kim, Gi‐Hoon Nam, Gi Beom Kim, Seohyun Kim, Yoonjeong Choi, Minsu Kwon, Ji-Hoon Han, Yeonsun Hong, Cherlhyun Jeong and Seohyun Kim and has published in prestigious journals such as Advanced Materials, Biomaterials and Macromolecules.

In The Last Decade

Seong A Kim

18 papers receiving 634 citations

Peers

Seong A Kim
Yoonjeong Choi South Korea
Wenqun Zhong China
Marine Cordonnier France
Yuanfan Yang United States
An Song China
Noemi Arrighetti Italy
Zhenguo Cheng China
Gaëtan Chanteloup France
Yangzhou Su China
Gi Beom Kim South Korea
Yoonjeong Choi South Korea
Seong A Kim
Citations per year, relative to Seong A Kim Seong A Kim (= 1×) peers Yoonjeong Choi

Countries citing papers authored by Seong A Kim

Since Specialization
Citations

This map shows the geographic impact of Seong A Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seong A Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seong A Kim more than expected).

Fields of papers citing papers by Seong A Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seong A Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seong A Kim. The network helps show where Seong A Kim may publish in the future.

Co-authorship network of co-authors of Seong A Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Seong A Kim. A scholar is included among the top collaborators of Seong A Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seong A Kim. Seong A Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wahab, Riajul, Seong A Kim, Cherlhyun Jeong, et al.. (2025). Targeted delivery of apelin using a novel extracellular vesicle platform for pulmonary arterial hypertension treatment. Biomaterials. 323. 123438–123438. 2 indexed citations
2.
3.
Han, Ji-Hoon, Seohyun Kim, Seong A Kim, et al.. (2024). Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity. Advanced Science. 11(25). e2308662–e2308662. 25 indexed citations
4.
Choi, Yoonjeong, Seong A Kim, Eun‐Hae Kim, et al.. (2024). Novel insights into paclitaxel’s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment. Journal for ImmunoTherapy of Cancer. 12(7). e008864–e008864. 17 indexed citations
5.
Kim, Gi Beom, Seohyun Kim, Seong A Kim, et al.. (2023). Harnessing Oncolytic Extracellular Vesicles for Tumor Cell‐Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy. Small. 19(37). e2300527–e2300527. 9 indexed citations
6.
Kim, Seong A, Seohyun Kim, Gi Beom Kim, et al.. (2022). Protein-based nanocages for vaccine development. Journal of Controlled Release. 353. 767–791. 26 indexed citations
7.
Hong, Yeonsun, Jiyoung Goo, Seong A Kim, et al.. (2022). Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy. Journal of Controlled Release. 351. 727–738. 27 indexed citations
8.
Kim, Seong A, Seohyun Kim, Gi Beom Kim, et al.. (2022). A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations. International Journal of Molecular Sciences. 23(11). 6123–6123. 13 indexed citations
9.
10.
Kim, Seohyun, Seong A Kim, Ji-Hoon Han, & In‐San Kim. (2021). Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential. International Journal of Molecular Sciences. 22(23). 12916–12916. 44 indexed citations
11.
Kwon, Minsu, Gi‐Hoon Nam, Seong A Kim, et al.. (2021). Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma. Cancer Letters. 522. 198–210. 25 indexed citations
12.
Choi, Yoonjeong, Gi‐Hoon Nam, Gi Beom Kim, et al.. (2021). Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity. Cancer Gene Therapy. 28(9). 960–970. 9 indexed citations
13.
Kim, Seong A, Gi‐Hoon Nam, Saurav Kumar Jha, et al.. (2021). Oral Cancer Immunotherapy through a Simvastatin‐Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity. Advanced Therapeutics. 4(11). 1 indexed citations
14.
Nam, Gi‐Hoon, Minsu Kwon, Seong A Kim, et al.. (2021). Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer. Journal for ImmunoTherapy of Cancer. 9(7). e002474–e002474. 58 indexed citations
15.
Kim, Seong A, Gi‐Hoon Nam, Saurav Kumar Jha, et al.. (2021). Oral Cancer Immunotherapy through a Simvastatin‐Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity. Advanced Therapeutics. 4(8). 1 indexed citations
16.
Nam, Gi‐Hoon, Yoonjeong Choi, Gi Beom Kim, et al.. (2020). Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy. Advanced Materials. 32(51). e2002440–e2002440. 223 indexed citations
17.
Hong, Yeonsun, Yoon Kyoung Kim, Gi Beom Kim, et al.. (2019). Degradation of tumour stromal hyaluronan by small extracellular vesicle‐PH20 stimulates CD103+ dendritic cells and in combination with PD‐L1 blockade boosts anti‐tumour immunity. Journal of Extracellular Vesicles. 8(1). 1670893–1670893. 57 indexed citations
18.
Geng, Jianxin, et al.. (2008). Synthesis of SWNT Rings by Noncovalent Hybridization of Porphyrins and Single-Walled Carbon Nanotubes. The Journal of Physical Chemistry C. 112(32). 12264–12271. 38 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoonjeong Choi Breakdown of academic impact, for papers by Wenqun Zhong Breakdown of academic impact, for papers by Marine Cordonnier Breakdown of academic impact, for papers by Yuanfan Yang Breakdown of academic impact, for papers by An Song Breakdown of academic impact, for papers by Noemi Arrighetti Breakdown of academic impact, for papers by Zhenguo Cheng Breakdown of academic impact, for papers by Gaëtan Chanteloup Breakdown of academic impact, for papers by Yangzhou Su Breakdown of academic impact, for papers by Gi Beom Kim
Rankless by CCL
2026